Tianjin Tianyao Pharmaceuticals Co Ltd (600488) — Cash Flow Quality Index
Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Cash Flow Quality Index of 0.65x as of September 2025. Operating cash flow of CN¥13.19 Million is below net income of CN¥20.24 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Tianjin Tianyao Pharmaceuticals Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tianjin Tianyao Pharmaceuticals Co Ltd Cash Flow Quality Index (2000–2024)
Historical Cash Flow Quality Index for Tianjin Tianyao Pharmaceuticals Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600488 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Year-by-year earnings quality comparison for Tianjin Tianyao Pharmaceuticals Co Ltd. For live market cap and the full company financial profile, see Tianjin Tianyao Pharmaceuticals Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.73x | CN¥569.37 Million | CN¥208.21 Million | ▼ -59.1% |
| 2023 | 6.69x | CN¥783.01 Million | CN¥117.05 Million | ▼ -81.1% |
| 2022 | 35.45x | CN¥653.52 Million | CN¥18.44 Million | ▲ +1115.5% |
| 2021 | 2.92x | CN¥316.89 Million | CN¥108.67 Million | ▼ -32.3% |
| 2020 | 4.31x | CN¥346.88 Million | CN¥80.58 Million | ▲ +182.3% |
| 2019 | 1.52x | CN¥279.37 Million | CN¥183.21 Million | ▲ +58.7% |
| 2018 | 0.96x | CN¥189.27 Million | CN¥196.96 Million | ▲ +2016.3% |
| 2017 | -0.05x | CN¥-8.15 Million | CN¥162.43 Million | ▼ -105.1% |
| 2016 | 0.99x | CN¥63.32 Million | CN¥63.97 Million | ▼ -39.8% |
| 2015 | 1.64x | CN¥129.50 Million | CN¥78.81 Million | ▼ -20.3% |
| 2014 | 2.06x | CN¥178.76 Million | CN¥86.72 Million | ▲ +26.8% |
| 2013 | 1.63x | CN¥84.55 Million | CN¥52.00 Million | ▲ +1116.0% |
| 2012 | 0.13x | CN¥13.23 Million | CN¥98.92 Million | ▼ -83.8% |
| 2011 | 0.82x | CN¥78.47 Million | CN¥95.12 Million | ▼ -34.5% |
| 2010 | 1.26x | CN¥116.82 Million | CN¥92.79 Million | ▼ -80.6% |
| 2009 | 6.49x | CN¥435.13 Million | CN¥67.07 Million | ▲ +52.9% |
| 2008 | 4.24x | CN¥219.31 Million | CN¥51.69 Million | ▼ -26.7% |
| 2007 | 5.79x | CN¥162.33 Million | CN¥28.04 Million | ▲ +412.1% |
| 2006 | 1.13x | CN¥50.72 Million | CN¥44.86 Million | ▲ +184.6% |
| 2005 | -1.34x | CN¥-108.87 Million | CN¥81.50 Million | ▼ -223.1% |
| 2004 | 1.08x | CN¥110.30 Million | CN¥101.68 Million | ▲ +115.2% |
| 2003 | 0.50x | CN¥45.77 Million | CN¥90.81 Million | ▲ +2.5% |
| 2002 | 0.49x | CN¥45.28 Million | CN¥92.08 Million | ▼ -48.4% |
| 2001 | 0.95x | CN¥71.87 Million | CN¥75.38 Million | ▲ +52.3% |
| 2000 | 0.63x | CN¥41.06 Million | CN¥65.58 Million | — |